Intrathecal alemtuzumab: a potential treatment of refractory leptomeningeal T-cell prolymphocytic leukemia

被引：7

作者：

Alsawah, Fares ^{[1
]}

Benitez, Lydia ^{[2
]}

Choi, Sarah ^{[3
]}

Marini, Bernard ^{[2
]}

Perissinotti, Anthony ^{[2
]}

Skyles, Amy ^{[2
]}

Burke, Patrick ^{[4
]}

Pettit, Kristen ^{[4
]}

Crouch, Ashley ^{[4
]}

Fox, Heather ^{[4
]}

Bixby, Dale ^{[4
]}

机构：

[1] Michigan Med, Dept Internal Med, Ann Arbor, MI USA

[2] Michigan Med, Dept Pharm Serv & Clin Sci, Ann Arbor, MI USA

[3] Univ Michigan, Michigan Med, Dept Pathol, Ann Arbor, MI 48109 USA

[4] Michigan Med, Dept Internal Med, Div Hematol & Med Oncol, F4811A UH South,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA

来源：

BLOOD ADVANCES | 2019年 / 3卷 / 21期

关键词：

ANTIBODY;

D O I：

10.1182/bloodadvances.2019000289

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：3333 / 3336

页数：4

共 13 条

[1] High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H [J].

Dearden, CE ;

Matutes, E ;

Cazin, B ;

Tjonnfjord, GE ;

Parreira, A ;

Nomdedeu, B ;

Leoni, P ;

Clark, FJ ;

Radia, D ;

Rassam, SMB ;

Roques, T ;

Ketterer, N ;

Brito-Babapulle, V ;

Dyer, MJS ;

Catovsky, D .

BLOOD, 2001, 98 (06) :1721-1726

[2] Management of prolymphocytic leukemia [J].

Dearden, Claire .

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, :361-367

[3] Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route [J].

Dearden, Claire E. ;

Khot, Amit ;

Else, Monica ;

Hamblin, Mike ;

Grand, Effie ;

Roy, Ashok ;

Hewamana, Saman ;

Matutes, Estella ;

Catovsky, Daniel .

BLOOD, 2011, 118 (22) :5799-5802

[4]

DYER MJS, 1989, BLOOD, V73, P1431

[5] Phase I trial of nelarabine in indolent leukemias [J].

Gandhi, Varsha ;

Tam, Constantine ;

O'Brien, Susan ;

Jewell, Roxanne C. ;

Rodriguez, Carlos O., Jr. ;

Lerner, Susan ;

Plunkett, William ;

Keating, Michael J. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (07) :1098-1105

[6] Central Nervous System Involvement of T-cell Prolymphocytic Leukemia Diagnosed with Stereotactic Brain Biopsy: Case Report [J].

Gocmen, Selcuk ;

Kutlay, Murat ;

Erikci, Alev ;

Atabey, Cem ;

Sayan, Ozkan ;

Haholu, Aptullah .

TURKISH JOURNAL OF HEMATOLOGY, 2014, 31 (01) :75-78

[7]

HALE G, 1988, LANCET, V2, P1394

[8]

HALE G, 1983, BLOOD, V62, P873

[9] Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed [J].

Keating, MJ ;

Cazin, B ;

Coutré, S ;

Birhiray, R ;

Kovacsovics, T ;

Langer, W ;

Leber, B ;

Maughan, T ;

Rai, K ;

Tjonnfjord, G ;

Bekradda, M ;

Itzhaki, M ;

Hérait, P .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :205-213

[10] T-cell prolymphocytic leukemia [J].

Khot, Amit ;

Dearden, Claire .

EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (03) :365-371

← 1 2 →